Provided by Stop Loss Group

Cell and Gene Therapy

Helps manage the rising costs of cell and gene therapy.

Cutting edge medical treatments often come at huge costs but with our Cell and Gene Therapy solutions, you can introduce your clients to these treatments at costs they can afford. 

The rising costs of providing gene and cell therapies show no signs of letting up but the need for them is increasing all the time. Cell therapies can cost anywhere between $700,000 to $2 million whereas gene therapies can have a cost ranging between $950,000 to $3.3m*. To help your clients manage these costs, Tokio Marine HCC – Stop Loss Group has partnered with Emerging Therapy Solutions to provide a best-in-class service when, and how, your clients need it.

Don’t let costs limit the care you provide to your clients – let us take care of that for them.

* ETS - Cost of therapy is based on current known cost from publicly available information. NOTE: For full indications and label information, please visit manufacturer websites. 

Documents & forms

Your team

Head office

225 Townpark Drive, Suite 250
Kennesaw, GA 30144

Contact photo
Guy Finley

Assistant Vice President, Sales - Organ Transplant

Related products

why choose tmhcc

Why choose Tokio Marine HCC?

Tokio Marine HCC is a leading specialty insurance group with offices in the United States, Mexico, the United Kingdom and Europe, transacting business in approximately 180 countries and underwriting more than 100 classes of specialty insurance.

More about us Financial strength

Not all products, coverages, or features may be available in all states. Restrictions, exclusions, limitations, and conditions apply and you should see your agent for more information. Certain products and services are provided through non-admitted insurance carriers and are not subject to certain State Guaranty Funds.

HCC Life Insurance Company operating as Tokio Marine HCC - Stop Loss Group